262 related articles for article (PubMed ID: 16784985)
1. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
[TBL] [Abstract][Full Text] [Related]
2. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
Beschorner R; Pantazis G; Jeibmann A; Boy J; Meyermann R; Mittelbronn M; Schittenhelm J
Acta Neuropathol; 2009 Jun; 117(6):667-75. PubMed ID: 19283393
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Gyure KA; Morrison AL
Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
Albrecht S; Rouah E; Becker LE; Bruner J
Mod Pathol; 1991 Sep; 4(5):610-4. PubMed ID: 1758873
[TBL] [Abstract][Full Text] [Related]
5. Choroid plexus tumors: a review of 28-year experience.
Strojan P; Popović M; Surlan K; Jereb B
Neoplasma; 2004; 51(4):306-12. PubMed ID: 15254663
[TBL] [Abstract][Full Text] [Related]
6. Notch receptors in human choroid plexus tumors.
Beschorner R; Waidelich J; Trautmann K; Psaras T; Schittenhelm J
Histol Histopathol; 2013 Aug; 28(8):1055-63. PubMed ID: 23479446
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
Ikota H; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of EAAT-1 and Kir7.1 for distinguishing endolymphatic sac tumors from choroid plexus tumors.
Schittenhelm J; Roser F; Tatagiba M; Beschorner R
Am J Clin Pathol; 2012 Jul; 138(1):85-9. PubMed ID: 22706862
[TBL] [Abstract][Full Text] [Related]
9. Choroid plexus tumors: an institutional series of 25 patients.
Menon G; Nair SN; Baldawa SS; Rao RB; Krishnakumar KP; Gopalakrishnan CV
Neurol India; 2010; 58(3):429-35. PubMed ID: 20644273
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining.
Kato T; Fujita M; Sawamura Y; Tada M; Abe H; Nagashima K; Nakamura N
Noshuyo Byori; 1996 Nov; 13(2):99-105. PubMed ID: 8958514
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the choroid plexus.
Rickert CH; Paulus W
Microsc Res Tech; 2001 Jan; 52(1):104-11. PubMed ID: 11135453
[TBL] [Abstract][Full Text] [Related]
12. Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience.
Bahar M; Hashem H; Tekautz T; Worley S; Tang A; de Blank P; Wolff J
J Neurooncol; 2017 May; 132(3):427-432. PubMed ID: 28290001
[TBL] [Abstract][Full Text] [Related]
13. P53 expression in choroid plexus neoplasms: an immunohistochemical study.
Jay V; Ho M; Chan F; Malkin D
Arch Pathol Lab Med; 1996 Nov; 120(11):1061-5. PubMed ID: 12049110
[TBL] [Abstract][Full Text] [Related]
14. Second surgery and the prognosis of choroid plexus carcinoma--results of a meta-analysis of individual cases.
Wrede B; Liu P; Ater J; Wolff JE
Anticancer Res; 2005; 25(6C):4429-33. PubMed ID: 16334121
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus.
Vajtai I; Varga Z; Aguzzi A
Histopathology; 1996 Aug; 29(2):147-51. PubMed ID: 8872148
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus].
Varga Z; Vajtai I
Orv Hetil; 1998 Mar; 139(13):761-5. PubMed ID: 9578705
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy.
Krieger MD; Panigrahy A; McComb JG; Nelson MD; Liu X; Gonzalez-Gomez I; Gilles F; Bluml S
Neurosurg Focus; 2005 Jun; 18(6A):E4. PubMed ID: 16048290
[TBL] [Abstract][Full Text] [Related]
18. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological study on choroid plexus tumors: immunohistochemical features and argyrophilic nucleolar organizer regions values].
Shirakawa N; Kannuki S; Matsumoto K
Noshuyo Byori; 1994; 11(1):99-105. PubMed ID: 8162158
[TBL] [Abstract][Full Text] [Related]
20. Divergent differentiation in choroid plexus papilloma. An immunohistochemical study of five cases.
Muthuphei MN
Cent Afr J Med; 1995 Mar; 41(3):103-4. PubMed ID: 7540506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
